Literature DB >> 7330165

Non-cirrhotic intrahepatic portal hypertension: A long term follow-up study.

J G Kingham, D A Levison, A G Stansfeld, A M Dawson.   

Abstract

The clinico-pathological features and prognosis of 59 cases of non-cirrhotic portal hypertension seen at one hospital over a 30-year period are described. Diagnosis was made on operative wedge liver biopsy in most cases. All but two had clinical features of portal hypertension and 47 had bled from oesophageal varices. In 53, portal decompression was performed without operative death or variceal rebleeding. Subsequent liver histology in 16 cases up to 18 years after diagnosis showed no change in the majority. The relatively static morphology was reflected in the clinical course. Twenty-two patients have died but only 11 as a result of liver disease or its treatment. Actuarial analysis shows the five year survival to be 90 per cent and the 30-year survival 55 per cent in strong contrast to the grim prognosis for cirrhosis. The infrequency of operative liver biopsies and unfamiliarity with the disease lead to underdiagnosis.

Entities:  

Mesh:

Year:  1981        PMID: 7330165

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  14 in total

1.  Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation.

Authors:  Sunil Taneja; Yogesh Chawla; Radha K Dhiman
Journal:  Hepatol Int       Date:  2011-09-03       Impact factor: 6.047

2.  Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study.

Authors:  Edward R Cachay; Michael R Peterson; Miguel Goicoechea; William C Mathews
Journal:  Br J Med Med Res       Date:  2011

3.  Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors.

Authors:  C E Eapen; Peter Nightingale; Stefan G Hubscher; Peter J Lane; Timothy Plant; Dimitris Velissaris; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2010-05-25       Impact factor: 3.199

Review 4.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

5.  Nodular regenerative hyperplasia mimicking cirrhosis of the liver.

Authors:  J A McDonald; D M Painter; N D Gallagher; G W McCaughan
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

Review 6.  Porto-hepatic venous shunt via portal vein aneurysm with splenomegaly.

Authors:  F Hanatate; H Matsuoka; Y Mizuno; T Kitamura
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

7.  Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.

Authors:  Ian Mackie; C E Eapen; Desley Neil; Andrew S Lawrie; Andrew Chitolie; Jean C Shaw; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

Review 8.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 9.  Extra hepatic portal venous obstruction.

Authors:  D R Triger
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

10.  Chronic portal-systemic encephalopathy with normal portal vein pressure possibly due to noncirrhotic portal fibrosis.

Authors:  M Takashi; M Igarashi; S Hino; N Goto; K Okuda
Journal:  Dig Dis Sci       Date:  1984-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.